David Ridley
Senior Editor – Europe
During his time at OTC bulletin, David focused mainly on the European OTC market, especially German-speaking countries: Germany, Austria and Switzerland). David is interested in European OTC, herbal/homeopathic, food supplement and self-care medical device regulation, and prescription-to-OTC switches in particular. Before working for OTC bulletin, David was a Lecturer in English and Journalism, and alongside his job David moonlights as a musician in a heavy metal band.
Remove Alert
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From David Ridley
No Plans To Remove CBD Products From Shelves, Says UK Food Regulator
CBD products already on the UK market are safe for now, as the country's Food Standards Agency says it will not take action while it works out how to implement the new European Union novel food regulations.
OTC Codeine Is 'Safe And Effective' – UK Industry Responds To BBC Exposé
Will the UK follow other countries and reverse-switch codeine to prescription-only status? British industry association, the PAGB, responds to a BBC documentary questioning the safety and efficacy of OTC codeine.
What A Relief! Three German IBS Launches From Sanofi, Dr Kade, Dr Loges
Sanofi on trend with plant-based, app-supported Buscopan line extension, Dr Kade offers all-in-one gastrointestinal product and Dr Loges appeals to children with blueberry flavored supplement.
Direct-To-Consumer Tests Opening The Door To Personalized Medicine
FEATURE: Could self-tests and personalized medicine revolutionize the global consumer healthcare market? HBW Insight talks to Atlas Biomed's Sergey Musienko about the future of the direct-to-consumer testing industry.
Spanish OTC Industry Round-Up: Esteve Buys Riemser, Cinfa Invests, ANEFP Trains Pharmacists
Esteve acquires Germany’s Riemser, Cinfa invests €200m over four years, and Spanish self-care association, ANEFP, restarts its successful pharmacy training program.
For Switch Success, Dive Deeper Into Consumer Behaviour
Behavioral insights can help companies make a success of Rx-to-OTC switches, explains Hamell’s managing director Fiona Hammond, in an exclusive interview with HBW Insight.